ATNM icon

Actinium Pharmaceuticals
ATNM

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $9.37M invested in Actinium Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

18% less capital invested

Capital invested by funds: $11.5M → $9.37M (-$2.12M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5M
Puts
$1.3M
Net Calls
Net Calls Change

Top Buyers

1
+$181K
2
+$126K
3
+$99K
4
William Blair & Company
William Blair & Company
Illinois
+$70K
5
Group One Trading
Group One Trading
Illinois
+$58.6K

Top Sellers

1
-$441K
2
-$341K
3
-$157K
4
DLG
Daniel L. Goodwin
-$60K
5
Morgan Stanley
Morgan Stanley
New York
-$51.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6K
27
$6K
28
$5K
29
$4K
30
$3K
31
$2K
32
$2K
33
$1.36K
34
$1K
35
$1K
36
–
37
–
38
–
39
–
40
–
1
2